GSK, Hospira Trade Blame For Failed Flu Vaccine Deal
A GlaxoSmithKline unit went to trial in Illinois on Monday in hopes of convincing a federal jury that fellow pharmaceutical company Hospira owes millions of dollars for breaking a contract to...To view the full article, register now.
Already a subscriber? Click here to view full article